BRUSSELS WEIGHING ON MEDICINES SUSPENSION FOLLOWING INDIAN CLINICAL DATA DOUBTS
February 8th, 2015
THE RE-EXAMINATION of European Union (EU) market authorisations following concerns over clinical trials conducted by GVK Biosciences in Hyderabad, India, has sparked intense debate in Brussels.A European Parliament hearing has heard comment and details about the recommendation from the European Medicine Agency’s committee for medicinal products for human use (CHMP) that some 800 forms and dosages of medicines approved in the EU be suspended. All approvals were based on clinical trials conducted by the Hyderabad branch of the Indian contract research ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.